Re‐treatment with radium‐223: 2‐year follow‐up from an international, open‐label, phase 1/2 study in patients with castration‐resistant prostate cancer and bone metastases
暂无分享,去创建一个
S. Severi | O. Sartor | G. Procopio | N. Mariados | L. Trandafir | D. Heinrich | E. Rosenbaum | D. Keizman | J. Trigo | K. Pulkkanen | A. Peer | Rui Li | S. Frank | C. Thellenberg Karlsson | L. Nordquist | V. Wagner | M. J. M. Mendez Vidal | M. J. Méndez Vidal